Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2025-12-24 @ 2:01 PM
NCT ID:
NCT06835595
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Ability to undergo an extensive neuropsychological evaluation
* Ability to sign informed consent for the study
* Diagnosed with idiopathic PD according to the latest revision of the MDS criteria
* On stable and optimal antiparkinsonian therapy for at least four weeks
Exclusion Criteria:
* Systemic diseases of significant severity, including cardiovascular and cerebrovascular conditions (e.g., active neoplasms requiring chemotherapy, or end-stage heart failure)
* Presence of any active neurological disease, in addition to PD
* Presence of a cochlear implant, ferromagnetic brain device or near the site of brain stimulation, pacemaker, brain electrodes for DBS, electromechanical devices with IPG, or any other implantable stimulator, including peripheral ones
* History of epilepsy
* History of cerebrovascular, tumor-related, infectious, or metabolic brain conditions predisposing to seizures or causing symptomatic epilepsy
* Pregnancy or breastfeeding
* Alcoholism
* Treatment with anticholinesterase drugs, benzodiazepines, neuroleptics, anticholinergics, or antidepressants in the last month
* Treatment with drugs that lower the seizure threshold (e.g., imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, MDMA, ecstasy, phencyclidine, ketamine, gamma-hydroxybutyrate, alcohol, theophylline)
* Active cochlear pathology (especially if currently receiving ototoxic drugs, such as aminoglycoside antibiotics)
* Dementia according to the latest revision of the MDS criteria for PDD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06835595
Study Brief:
Protocol Section:
NCT06835595